RMC-4998
$250.00
CAS No.: 2642037-07-6
Catalog No.: 200967
Purity: 98%
MF: C57H74N8O7
MW: 983.25
Storage: 2-8 degree Celsius
SMILES: O=C(N1CCC[C@@H](C2=O)N1)[C@@H](NC([C@H](C(C)C)N3C([C@@]4(CCN(C(C#CC(C)(C)N(C)C)=O)C4)CC3)=O)=O)CC5=CC(C6=CC(C(CC(C)(C)CO2)=[C@@]([C@@]7=C([C@H](C)OC)N=CC=C7)N8CC)=C8C=C6)=CC=C5
Catalog No.: 200967
Purity: 98%
MF: C57H74N8O7
MW: 983.25
Storage: 2-8 degree Celsius
SMILES: O=C(N1CCC[C@@H](C2=O)N1)[C@@H](NC([C@H](C(C)C)N3C([C@@]4(CCN(C(C#CC(C)(C)N(C)C)=O)C4)CC3)=O)=O)CC5=CC(C6=CC(C(CC(C)(C)CO2)=[C@@]([C@@]7=C([C@H](C)OC)N=CC=C7)N8CC)=C8C=C6)=CC=C5
For R&D use only. Not for human or animal use.
RMC-4998 CAS No.: 2642037-07-6 is an orally active inhibitor targeting the active or GTP-bound state of the KRASG12C mutant. RMC-4998 can form a ternary complex with intracellular CYPA and the activated KRASG12C mutant, with an IC50 value of 28 nM. RMC-4998 can inhibit ERK signaling in KRASG12C mutant cancer cells and induce apoptosis. RMC-4998 can be used for tumor research.
Related Products:
Daraxonrasib (RMC-6236) CAS No.: 2765081-21-6 https://www.chemshuttle.com/catalogsearch/result/?q=2765081-21-6&cat=
Zoldonrasib (RMC-9805; KRAS G12D inhibitor 18) CAS No.: 2922732-54-3 https://www.chemshuttle.com/catalogsearch/result/?q=2922732-54-3&cat=
RMC-7977 CAS No.: 2765082-12-8 https://www.chemshuttle.com/catalogsearch/result/?q=2765082-12-8&cat=
Elironrasib (RMC-6291) CAS No.: 2641998-63-0 https://www.chemshuttle.com/catalogsearch/result/?q=2641998-63-0&cat=
RMC-5127 CAS No.: 3056146-38-1 https://www.chemshuttle.com/catalogsearch/result/?q=3056146-38-1&cat=
RM-018 CAS No.: 2641993-55-5 https://www.chemshuttle.com/catalogsearch/result/?q=2641993-55-5&cat=
RAS/RAS-RAF-IN-1 CAS No.: 2447039-81-6 https://www.chemshuttle.com/catalogsearch/result/?q=2447039-81-6&cat=
Reviews
Write Your Own Review